Evidence map›Paper›PMID 20160000›Full record

ArticleRadiology2010

Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways.

Stephanie A Solazzo, Muneeb Ahmed, Rachel Schor-Bardach, Wei Yang, Geoffrey D Girnun, Syed Rahmanuddin, Tatyana Levchenko, Sabina Signoretti, Douglas R Spitz, Vladimir Torchilin and 1 more

Abstract read
In one paragraph

Article in Radiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Precision Oncology: Advances in Drug Delivery and Imaging.Recent advances in drug delivery and formulation · 2025
    Review
  6. Article
  7. Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. CD133Scientific reports · 2017
    Article
  17. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Stephanie A SolazzoLaboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215, USA.
Muneeb Ahmed
Rachel Schor-Bardach
Wei Yang
Geoffrey D Girnun
Syed Rahmanuddin
Tatyana Levchenko
Sabina Signoretti
Douglas R Spitz
Vladimir Torchilin
S Nahum Goldberg
Beth Israel Deaconess Medical Center · USNortheastern University · USBrigham and Women's Hospital · USUniversity of Iowa · USUniversity of Maryland, Baltimore · US

Funding

LONG-CIRCULATING POLYMER-MODIFIED LIPOSOMESR01HL055519 · NHLBI · NORTHEASTERN UNIVERSITY · PI TORCHILIN, VLADIMIR P · 1997 to 2008
$2.0M
Metabolic Oxidative Stress in Human Cancer CellsR01CA100045 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 2004 to 2008
$1.8M
The Use of 2-Deoxyglucose in Head and Neck Cancer TherapyR01CA133114 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA100045NCI NIH HHS R01 CA133114NHLBI NIH HHS 2R01 HL55519NHLBI NIH HHS R01 HL055519
6 · The paper itself

Abstract

purposeTo determine if oxidative and nitrative stress and/or apoptosis contribute to increased coagulation when combining radiofrequency (RF) ablation with liposomal doxorubicin. MATERIALS AND

methodsAnimal care committee approval was obtained. R3230 mammary adenocarcinomas in Fischer rats were treated with either RF ablation (n = 43), 1 mg of intravenously injected liposomal doxorubicin (n = 26), or combined therapy (n = 30) and were compared with control subjects (n = 11). A subset of animals receiving combination therapy (n = 24) were treated in the presence or absence of N-acetylcysteine (NAC) administered 24 hours and 1 hour before RF ablation. Tumors were analyzed 2 minutes to 72 hours after treatment to determine the temporal range of response by using immunohistochemical staining of the apoptosis marker cleaved caspase-3, phosphorylated gammaH2AX, and HSP70 and of markers of oxidative and nitrative stress (8-hydroxydeoxyguanosine [8-OHdG], 4-hydroxynonenal [4-HNE]-modified proteins, and nitrotyrosine [NT]). Statistical analyses, including t tests and analysis of variance for comparisons where appropriate, were performed.

resultsBy 4 hours after RF ablation alone, a 0.48-mm +/- 0.13 (standard deviation) peripheral band with 57.0% +/- 7.3 cleaved caspase-3 positive cells was noted at the ablation margin, whereas a 0.73-mm +/- 0.18 band with 77.7% +/- 6.3 positivity was seen for combination therapy (P < .03 for both comparisons). Combination therapy caused increased and earlier staining for 4-HNE-modified proteins, 8-OHdG, NT, and gammaH2AX with colocalization to cleaved caspase-3 staining. A rim of increased HSP70 was identified peripheral to the area of cleaved caspase-3. Parameters of oxidative and nitrative stress were significantly inhibited by NAC 1 hour following RF ablation, resulting in decreased cleaved caspase-3 positivity (0.28-mm +/- 0.09 band of 25.9% +/- 7.4 positivity vs 0.59-mm +/- 0.11 band of 62.9% +/- 6.0 positivity, P < .001 for both comparisons).

conclusionCombining RF ablation with liposomal doxorubicin increases cell injury and apoptosis in the zone of increased coagulation by using a mechanism that involves oxidative and nitrative stress that leads to accelerated apoptosis.

Indexed as

Catheter Ablation8-Hydroxy-2'-DeoxyguanosineAcetylcysteineAldehydesAnimalsApoptosisCaspase 3Combined Modality TherapyDeoxyguanosineDNA DamageDoxorubicinFemaleHistonesHSP70 Heat-Shock ProteinsImmunoenzyme TechniquesMammary Neoplasms, Experimental3-nitrotyrosine4-hydroxy-2-nonenal8-Hydroxy-2'-DeoxyguanosineAcetylcysteineAldehydesCaspase 3DeoxyguanosineDoxorubicinHistonesHSP70 Heat-Shock ProteinsTyrosine

Identifiers

PMID20160000
PMCPMC2843831
OpenAlexW2162269896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.